NDC 69097-664
ICATIBANT
Icatibant
ICATIBANT is a Subcutaneous Injection in the Human Prescription Drug category. It is labeled and distributed by Cipla Usa Inc.. The primary component is Icatibant Acetate.
| Product ID | 69097-664_38971837-750d-4016-bc05-618d00dacf0d |
| NDC | 69097-664 |
| Product Type | Human Prescription Drug |
| Proprietary Name | ICATIBANT |
| Generic Name | Icatibant |
| Dosage Form | Injection |
| Route of Administration | SUBCUTANEOUS |
| Marketing Start Date | 2020-07-13 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA212446 |
| Labeler Name | Cipla USA Inc. |
| Substance Name | ICATIBANT ACETATE |
| Active Ingredient Strength | 30 mg/3mL |
| Pharm Classes | Bradykinin B2 Receptor Antagonist [EPC], Bradykinin B2 Receptor Antagonists [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |